Get the Stockscreener App
15.71
6.88%
-1.16
Pre-market:
15.70
-0.01
-0.06%
Core Laboratories Inc stock is traded at $15.71, with a volume of 577.35K.
It is down -6.88% in the last 24 hours and down -10.59% over the past month.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
See More
Previous Close:
$16.87
Open:
$16.05
24h Volume:
577.35K
Relative Volume:
1.49
Market Cap:
$731.51M
Revenue:
$526.52M
Net Income/Loss:
$32.53M
P/E Ratio:
23.32
EPS:
0.6738
Net Cash Flow:
$23.29M
1W Performance:
-3.56%
1M Performance:
-10.59%
6M Performance:
+25.78%
1Y Performance:
+0.96%
1-Day Range:
$15.45
$16.76
1-Week Range:
$15.45
$17.07
52-Week Range:
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Name
Core Laboratories Inc
Sector
Industry
Phone
713-328-2673
Address
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, TS, FTI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
15.71 | 731.51M | 526.52M | 32.53M | 23.29M | 0.6738 |
SLB
Slb Ltd
|
50.51 | 75.82B | 35.69B | 3.45B | 4.54B | 2.3617 |
BKR
Baker Hughes Company
|
63.49 | 62.74B | 27.73B | 2.62B | 2.54B | 2.605 |
HAL
Halliburton Co
|
38.11 | 31.92B | 22.18B | 1.29B | 1.67B | 1.5088 |
TS
Tenaris S A Adr
|
57.23 | 28.89B | 12.00B | 1.98B | 2.02B | 2.7949 |
FTI
Technipfmc Plc
|
70.16 | 28.06B | 9.93B | 967.10M | 1.45B | 2.3076 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Jun-30-23 | Downgrade | Citigroup | Neutral → Sell |
| Apr-18-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-07-22 | Upgrade | Citigroup | Sell → Neutral |
| Sep-26-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Apr-18-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Oct-18-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-09-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-14-21 | Downgrade | Citigroup | Neutral → Sell |
| Dec-18-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-11-20 | Reiterated | Cowen | Market Perform |
| Oct-13-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Sep-29-20 | Upgrade | ABN Amro | Sell → Hold |
| Jul-16-20 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Apr-13-20 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Mar-09-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-31-20 | Reiterated | Cowen | Market Perform |
| Jan-30-20 | Resumed | Johnson Rice | Buy |
| Jan-14-20 | Initiated | Bernstein | Mkt Perform |
| Jan-02-20 | Downgrade | Stifel | Buy → Hold |
| Dec-31-19 | Reiterated | Cowen | Market Perform |
| Jul-10-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-25-19 | Upgrade | Tudor Pickering | Hold → Buy |
| Dec-19-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-16-18 | Upgrade | Guggenheim | Neutral → Buy |
| Nov-01-18 | Upgrade | ABN Amro | Sell → Buy |
| Oct-29-18 | Reiterated | Cowen | Market Perform |
View All
Core Laboratories Inc Stock (CLB) Latest News
History Review: Is Core Laboratories Inc backed by strong institutional buying2026 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
Core Laboratories (NYSE:CLB) Shares Gap DownHere's Why - MarketBeat
Here’s Why Maintaining a Hold Position Is Suitable for Core Laboratories Shares at This Time - Bitget
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now - Yahoo Finance
Core Lab (CLB) Revises Q1 Revenue Forecast Amid Regional Challen - GuruFocus
Core Laboratories Cuts Q1 Guidance to Account for Middle East Conflict - Moomoo
Stocks to Watch: Core Laboratories, Bark - Moomoo
Core Laboratories (CLB) Shares Drop 4.7% After Lower Q1 Guidance - GuruFocus
Core Labs cuts Q1 guidance, citing impact of Middle East war (CLB:NYSE) - Seeking Alpha
CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE - Bitget
Core Laboratories cuts Q1 2026 guidance on Middle East conflict - Investing.com
Core Laboratories (CLB) Shares Fall 5% Following Preliminary Q1 Results - GuruFocus
Core Laboratories Cuts Q1 2026 Guidance Amid Mideast Turmoil - TipRanks
Core Laboratories Sees Q1 Adj EPS $0.05-$0.07... - Benzinga
Core Laboratories Expects Q1 2026 Revenue An... - Benzinga
Core revises Q1 2026 guidance, now sees revenue $119M-$123M and EPS $0.05-$0.07 - TradingView
Core Laboratories Inc. Revises Earnings Guidance for the First Quarter 2026 - marketscreener.com
Core Laboratories (NYSE: CLB) trims Q1 2026 guidance amid Middle East turmoil - Stock Titan
Core Laboratories Inc. 2025 Annual Report – Business Overview, Strategy, Operations, and Climate Initiatives - Minichart
Core Laboratories 10-K: $526.5M Revenue, $0.65 Diluted EPS - TradingView
CWA Asset Management Group LLC Makes New Investment in Core Laboratories Inc. $CLB - MarketBeat
Core Laboratories (NYSE: CLB) outlines global operations, 2025 revenue and key risk exposures - Stock Titan
Core Laboratories Revises Financials Following Tax Review () - aktiencheck.de
Core Laboratories Inc. Files Form 8-K/A SEC Report for February 2026 – Company Information and Filing Details - Minichart
Core Laboratories (NYSE: CLB) trims 2025 EPS after $4.2M tax adjustment - Stock Titan
Core Laboratories Inc. $CLB Shares Sold by Earnest Partners LLC - MarketBeat
CORE LABORATORIES' SECOND QUARTER 2022 WEBCAST AT 7:30 A.M. CDT / 2:30 P.M. CEST ON JULY 28, 2022 - Nasdaq
ProPetro (PUMP) Jumps 9.9%: Does the Stock Have More Room to Grow? - Bitget
Core Laboratories (NYSE:CLB) Shares Cross Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Total equity of Core Laboratories Inc. – DUS:HJ1 - TradingView
Core Laboratories Inc. Earnings and Revenue – DUS:HJ1 - TradingView
Quick ratio of Core Laboratories Inc. – DUS:HJ1 - TradingView
Debt to assets ratio of Core Laboratories Inc. – DUS:HJ1 - TradingView
Gross profit of Core Laboratories Inc. – DUS:HJ1 - TradingView
Core Laboratories Inc. (CLB) gains on sequential revenue growth and Solintec acquisition - MSN
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Will Core Laboratories Inc. stock benefit from upcoming earnings reportsMarket Weekly Review & Fast Moving Stock Trade Plans - Naître et grandir
Core Laboratories (CLB) Gains on Sequential Revenue Growth and Solintec Acquisition - Insider Monkey
Why Is Core Laboratories (CLB) Down 14.2% Since Last Earnings Report? - Yahoo Finance
Core Laboratories Eases Shareholder Threshold for Major Deals - TipRanks
Royce & Associates LP Has $5.44 Million Holdings in Core Laboratories Inc. $CLB - MarketBeat
CLB SEC FilingsCore Laboratories Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Core Laboratories Delays 2025 Annual 10-K Filing - TipRanks
Core Laboratories (CLB) delays 2025 10-K amid international tax, control review - Stock Titan
CLB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Q1 EPS Forecast for Core Laboratories Lifted by Analyst - Defense World
Zacks Research Issues Optimistic Forecast for CLB Earnings - MarketBeat
CLB (Core Laboratories) ROC % : 5.95% (As of Dec. 2025) - GuruFocus
Core Laboratories (NYSE:CLB) Shares Surge Past Key Trend Line Nyse Composite Today - Kalkine Media
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World
Core Laboratories Inc Stock (CLB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):